March 2016 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for March 2016. This roundup includes the latest...
Under-Dosing Worsens Prognosis for PD Patients With Infection
Findings among patients with Parkinson's disease admitted to the hospital with pneumonia, UTI
Continuous-Flow Production of Pharmaceuticals Feasible
Continuous-flow synthesis of active drugs demonstrated in compact reconfigurable platform
Child Mental Health Care Varies Widely in Primary Care Settings
Prevalence of mental health diagnosis, psychotropic medication prescribing vary across U.S. practices
Renal Function Key to Cardiac Outcome in Statin-Treated CHD
Intrastudy stabilization, increase in eGFR linked to reduced MCVE rate in atorvastatin-treated patients
Omalizumab Effective for Chronic Spontaneous Urticaria
Treatment improves quality of life, cuts angioedema recurrence
Early Menopause Estradiol Tx Cuts Atherosclerosis Advance
Positive effect seen only on carotid-artery intima-media thickness
Baricitinib Superior to Placebo in Refractory Rheumatoid Arthritis
Findings based on patients with previous inadequate response to biologics
Guidelines Updated on Duration of Dual Antiplatelet Tx in CAD
Longer-duration tx represents trade-off between decreased risk of cardiac events, increased bleeding
Pioglitazone Linked to Increased Risk of Bladder Cancer
Duration- and dose-response associations for pioglitazone; no correlation for rosiglitazone
